# Arginine and Buphenyl in Patients With Argininosuccinic Aciduria (ASA), a Urea Cycle Disorder

> **NCT00345605** · PHASE2 · COMPLETED · sponsor: **Brendan Lee** · enrollment: 12 (actual)

## Conditions studied

- Argininosuccinic Aciduria
- Amino Acid Metabolism, Inborn Errors
- Urea Cycle Disorders

## Interventions

- **DRUG:** Sodium Phenylbutyrate
- **DRUG:** Arginine

## Key facts

- **NCT ID:** NCT00345605
- **Lead sponsor:** Brendan Lee
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2011-05
- **Final completion:** 2012-11
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2018-01-31

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00345605

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00345605, "Arginine and Buphenyl in Patients With Argininosuccinic Aciduria (ASA), a Urea Cycle Disorder". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00345605. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*